Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial
J
Jing Tang
Y
Yongqiang Yang
D
Dongen Liu
B
Bicheng Wang
Z
Zhenyu Lin
Z
Zilong Wu
J
Jinfeng Zhang
D
Dejun Zhang
Y
Yaqin Liu
(Department of Chemistry)
M
Minghui Ge
L
Lei Chen
G
Gang Wu
T
Tao Zhang
J
Jun Xue
Article Details
Journal
Nature Communications
Volume / Issue
Vol. 17, Issue 1
Published
December 18, 2025
ISSN
2041-1723
Publisher
Nature Portfolio
Authors (14)
J
Jing Tang
Y
Yongqiang Yang
D
Dongen Liu
B
Bicheng Wang
Z
Zhenyu Lin
Z
Zilong Wu
J
Jinfeng Zhang
D
Dejun Zhang
Y
Yaqin Liu
Department of Chemistry
M
Minghui Ge
L
Lei Chen
G
Gang Wu
T
Tao Zhang
J
Jun Xue
Related Articles from this Journal
Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization
Chao Wu, Xu Zhang et al.
Aug 2026
10.1038/s41467-026-76516-1
Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses
Connor Weidle, Natalie Brunette et al.
Aug 2026
10.1038/s41467-026-76114-1
Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk
Ludmila Prokunina-Olsson, Oscar Florez-Vargas et al.
Aug 2026
10.1038/s41467-026-76157-4
Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants
Weiwei Jin, Wen Cao et al.
Aug 2026
10.1038/s41467-026-76470-y
Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain
Bongmin Bae, Katherine Gu et al.
Aug 2026
10.1038/s41467-026-76506-3